Edition:
United States

Bioanalytical Systems Inc (BASI.OQ)

BASI.OQ on NASDAQ Stock Exchange Capital Market

1.82USD
4:00pm EDT
Change (% chg)

$-0.03 (-1.62%)
Prev Close
$1.85
Open
$1.83
Day's High
$1.86
Day's Low
$1.80
Volume
3,583
Avg. Vol
7,900
52-wk High
$2.42
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

Bioanalytical Systems reports Q3 earnings per share of $0.03
Monday, 14 Aug 2017 10:53am EDT 

Aug 14 (Reuters) - Bioanalytical Systems Inc ::Q3 earnings per share $0.03.Qtrly ‍revenue amounted to $5.8 million, up 15 percent.  Full Article

Bioanalytical systems inc says entered into credit agreement with First Internet Bank Of Indiana - SEC filing
Tuesday, 27 Jun 2017 10:08am EDT 

June 27 (Reuters) - Bioanalytical Systems Inc :Bioanalytical Systems Inc - entered into a credit agreement with first internet bank of indiana - sec filing.Bioanalytical Systems Inc - credit agreement provides company with a term loan in amount of $4.5 million.Bioanalytical Systems Inc - credit agreement provides co with revolving line of credit of up to $2 million.Bioanalytical Systems Inc - term loan and facility mature June 23, 2022 and June 23, 2019, respectively.  Full Article

BASI reports Q2 earnings per share $0.05
Monday, 15 May 2017 08:30am EDT 

May 15 (Reuters) - Bioanalytical Systems Inc :BASI reports second quarter results.Q2 earnings per share $0.05.Q2 revenue rose 19 percent to $6.359 million.Bioanalytical Systems Inc - board has directed management to seek alternatives that will enable company to repay its indebtedness to Huntington Bank.Bioanalytical Systems-evaluating among others, potential disposition of certain assets, possible sale of West Lafayette building to repay indebtedness.Bioanalytical Systems Inc - board continues to weigh options and timing for hiring a new CEO, to fill position vacated in November of 2016.Bioanalytical Systems Inc- qtrly revenue rose on preclinical services revenues due to an overall rise in number of studies in Q2 versus prior year period.  Full Article

BASI Q1 EPS $0.00
Tuesday, 14 Feb 2017 08:30am EST 

Bioanalytical Systems Inc : BASI reports first quarter results . Q1 earnings per share $0.00 . Q1 revenue rose 26 percent to $6.174 million . Bioanalytical Systems - board has directed management to seek alternatives to enable co to repay indebtedness to Huntington Bank in full . Bioanalytical Systems - continues to explore initiatives to address credit issues, including but not limited to, potential disposition of certain assets . Bioanalytical Systems Inc - company continues to explore initiatives such as possible sale and leaseback of building in West Lafayette, Indiana . Bioanalytical Systems Inc - management has been, and continues to be actively engaged in more effectively controlling operating costs .Bioanalytical Systems Inc - board of directors continues to weigh options for replacing chief executive officer.  Full Article

Bioanalytical Systems says co entered into fifth forbearance agreement and sixth amendment to credit agreement
Wednesday, 1 Feb 2017 01:44pm EST 

Bioanalytical Systems Inc : Bioanalytical Systems - effective Jan 31, co entered into a fifth forbearance agreement and sixth amendment to credit agreement - SEC filing .Bioanalytical Systems Inc - fifth forbearance agreement amends maturity dates for term and revolving loans under credit agreement to July 31, 2017.  Full Article

Bioanalytical Systems Q4 loss per share $0.25
Thursday, 22 Dec 2016 08:30am EST 

Bioanalytical Systems Inc : Bioanalytical Systems - management to seek alternatives to enable co to repay indebtedness to Huntington bank in full upon expiration of forbearance period . BASi reports fiscal 2016 full year and fourth quarter results . Q4 loss per share $0.25 .Q4 revenue rose 3.6 percent to $5.154 million.  Full Article

Bioanalytical Systems' CEO Jacqueline Lemke to resign
Tuesday, 8 Nov 2016 05:52pm EST 

Bioanalytical Systems Inc : Bioanalytical Systems - on Nov 2, Jacqueline Lemke informed board of her intent to resign from her positions of president and chief executive officer .Says co's board of directors is in process of identifying Lemke's successor.  Full Article

Bioanalytical Systems entered third forbearance agreement,fourth amendment to credit agreement-SEC filing
Monday, 3 Oct 2016 11:37am EDT 

Bioanalytical Systems Inc : Effective Sept 30, Co entered third forbearance agreement ,fourth amendment to credit agreement-SEC filing . Third forbearance agreement amends maturity dates for term and revolving loans under credit agreement to october 31, 2016 . Third forbearance agreement removes additional financial covenant contained in second forbearance agreement .In connection with third forbearance agreement, CO agreed to reimburse Huntington Bank for certain legal fees ,to pay a loan forbearance fee..  Full Article

Basi Q3 loss per share $0.05
Thursday, 11 Aug 2016 08:30am EDT 

Bioanalytical Systems Inc : Basi reports third quarter results .Q3 revenue fell 17.8 percent to $5.053 million.  Full Article

Bioanalytical Systems elects Larry Boulet as Board's chairman
Thursday, 4 Aug 2016 02:03pm EDT 

Bioanalytical Systems Inc :On July 28, company’s board of directors voted unanimously to elect Larry Boulet as chairman of the board - SEC Filing.  Full Article

BRIEF-Bioanalytical Systems reports Q3 earnings per share of $0.03

* Qtrly ‍revenue amounted to $5.8 million, up 15 percent Source text: (http://bit.ly/2uH6Zlw) Further company coverage: